These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15822867)

  • 1. [Gonadorelin antagonists: present and future ].
    Bouchard P
    Rev Prat; 2005; Spec. No():25-7. PubMed ID: 15822867
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles?
    Gupta RK; Flaws JA
    Fertil Steril; 2005 May; 83(5):1339-42. PubMed ID: 15866566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GnRH agonists versus antagonists in fertilization in vitro].
    Frydman R
    Rev Prat; 2005; Spec. No():30-4. PubMed ID: 15822869
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term suppression of reproductive function by a single dose of gonadotropin-releasing hormone antagonists in a sheep model.
    Gonzalez-Bulnes A; Souza CJ; Scaramuzzi RJ; Campbell BK; Baird DT
    Fertil Steril; 2006 Oct; 86(4 Suppl):1121-8. PubMed ID: 16952359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
    Danforth DR; Arbogast LK; Friedman CI
    Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ; Nulsen JC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotroph adenomas.
    Samuels MH
    Curr Ther Endocrinol Metab; 1994; 5():52-6. PubMed ID: 7704786
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine effects of the GnRH antagonist, acyline, in domestic dogs.
    García Romero G; Valiente C; Aquilano D; Corrada Y; Gobello C
    Theriogenology; 2009 May; 71(8):1234-7. PubMed ID: 19193431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of single short-acting doses of GnRH antagonist modifies pituitary and follicular function in sheep.
    Lopez-Alonso C; Encinas T; Garcia-Garcia RM; Veiga-Lopez A; Ros JM; McNeilly AS; Gonzalez-Bulnes A
    Domest Anim Endocrinol; 2005 Oct; 29(3):476-87. PubMed ID: 16153498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Fauser BC; Devroey P
    Fertil Steril; 2005 Jun; 83(6):1607-11. PubMed ID: 15950626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and function of luliberin (author's transl)].
    Rzeszotarska B; Kozłowska I
    Postepy Biochem; 1980; 26(3):411-42. PubMed ID: 6782561
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles.
    Lee TH; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Fertil Steril; 2006 Oct; 86(4):1020-2. PubMed ID: 16963037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.
    Bosch E; Escudero E; Crespo J; Simón C; Remohí J; Pellicer A
    Fertil Steril; 2005 Nov; 84(5):1529-32. PubMed ID: 16275263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile secretion of hormones: significance and a tentative idea of future research.
    Lei H
    Chin Med J (Engl); 1996 Jul; 109(7):499-500. PubMed ID: 9206090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apoptosis of the follicular cells: its implication in ovarian induction protocols].
    Maillet G; Féral C; Benhaïm A
    Gynecol Obstet Fertil; 2005 Sep; 33(9):653-8. PubMed ID: 16137911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pituitary effects of GnRH.
    Pawson AJ; McNeilly AS
    Anim Reprod Sci; 2005 Aug; 88(1-2):75-94. PubMed ID: 15982836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder.
    Frankfurter D; Dayal M; Dubey A; Peak D; Gindoff P
    Fertil Steril; 2007 Nov; 88(5):1442-5. PubMed ID: 17481626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
    Heitman LH; Ijzerman AP
    Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
    Engel JB; Schally AV
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.